Clinical Trials Browser

Phase 2 × Not yet recruiting × Cholangiocarcinoma × Clear all

NCT07478523 2026-03-17

FAPDIG

Phase 2 Not yet recruiting

Gastrointestinal

Cholangiocarcinoma

NCT07432568 2026-02-25

A Study of Liposomal Irinotecan Plus 5-FU/LV HAIC With Lenvatinib and a PD-1 Inhibitor in Advanced ICC

Phase 2 Not yet recruiting

Gastrointestinal

Cholangiocarcinoma

NCT07353827 2026-01-20

FOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma

Phase 2 Not yet recruiting

Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT07296666 2025-12-22

Adjuvant Chemotherapy for BTC Based on 3D-PTA

Phase 2 Not yet recruiting

Gastrointestinal

Cholangiocarcinoma

NCT07128290 2025-08-17

PEHRICCA

Phase 2 Not yet recruiting

Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT07030140 2025-06-22

Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma

Phase 2 Not yet recruiting

Gastrointestinal

Bile Duct Neoplasms, Biliary Tract Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT05039892 2025-05-20

Efficacy and Safety of 3D185 Monotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Cholangiocarcinoma

Phase 2 Not yet recruiting

Gastrointestinal

Cholangiocarcinoma

NCT06946849 2025-04-27

SED-RO-ICC

Phase 2 Not yet recruiting

Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT06648525 2024-10-18

Adebrelimab Combined with Irinotecan Liposomes, 5-FU, CF ± Lenvatinib As First-line Treatment for Advanced ICC

Phase 2 Not yet recruiting

Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT06567600 2024-08-22

Low-dose Gemcitabine and Cisplatin and PD-1/PD-L1 Antibody Therapy in Intrahepatic Cholangiocarcinoma

Phase 2 Not yet recruiting

Gastrointestinal

Cholangiocarcinoma

NCT06530823 2024-07-31

Pemigatinib Combined With Durvalumab for Previously Treated Biliary Tract Carcinoma

Phase 2 Not yet recruiting

Gastrointestinal

Cholangiocarcinoma

NCT06519110 2024-07-25

CVL009-C2001

Phase 2 Not yet recruiting

GastrointestinalGynecologicHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Salivary Gland Neoplasms, Cholangiocarcinoma

NCT06375642 2024-04-19

A Single Arm, Single Centered Phase II Trial on the Combination of Adebrelimab, Surufatinib and Irinotecan Liposome-based HAIC in Advanced iCC

Phase 2 Not yet recruiting

Gastrointestinal

Cholangiocarcinoma